Pharma Job Work Management: Tracking Batches Across Contract Manufacturers

Pharma manufacturing routinely splits production across multiple sites: your own facility for some steps, contract manufacturers for others — granulation here, compression there, packaging at a third site. Each handoff is a place where batch traceability, in-process inventory, and regulatory documentation can fracture. The cost of a broken handoff in pharma is measured in regulatory observations, not just delays.

Here's how to maintain batch traceability across the boundary between your facility and a contract manufacturer (CMO).

Treat the CMO as Part of Your Production Network

The most common failure mode is treating the CMO as a black box: send raw material in, get finished intermediate out, hope the paperwork is right. The correct model treats the CMO as an extension of your own production — same batch record format, same in-process checks, same data flowing into your system.

A Shared Batch Identifier

The batch that leaves your facility and the batch that arrives at the CMO and the batch that returns from the CMO must share a single identifier. If your batch number is MAK-2026-0142, that number stays with the material at the CMO. CMO internal IDs are fine for their floor, but your master batch number is the spine of traceability.

Material Issued Under a Job Work Challan

Under Indian rules (Section 143 of CGST and equivalent state rules), material sent to a CMO travels under a job work challan, not a tax invoice. The challan must reference the batch, the destination, the expected return date, and the quantity. Skipping or sloppy challans is a tax compliance issue and a traceability issue simultaneously.

In-Process Inventory at the CMO

At any moment, material is at three potential states: in transit to CMO, in-process at CMO, in transit back. Your system must show stock in all three states, not collapse them into "out at CMO." Without this view, you can't answer "how much of batch 142 is at the CMO right now" — and the auditor will ask.

Receiving Back: QC Before Stock

When the intermediate or finished material returns, it goes into quarantine, not into available stock. QC sampling, testing, and release happen before it's available for the next step. CMO returns that go straight into available stock are how out-of-spec material reaches end-users.

Audit Trail Across the Boundary

Who approved sending which lot to which CMO? Which CMO operator processed it? Which equipment was used? Which CMO batch records were generated? The audit trail must be reconstructible across the boundary. A CMO that won't share batch records on demand is a CMO that can't be part of a regulated supply chain.

The Operational Reality

Most SME pharma operations manage this in Excel and WhatsApp, which works at 2–3 CMOs and 4–5 batches a month. Past that, you need a system that treats job work as a first-class workflow. The factories that scale without a regulatory event are the ones that build this visibility before they're forced to.